drugset / Trial / NCT02248480

A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan

NCT02248480 ↗

Phase 3 Completed 354 enrolled Eli Lilly and Company Shionogi · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.

Timeline

Start
2014-10
Primary completion
2015-06
Completion
2015-06

Outcome

Met primary endpoint

paper BPI-Severity average pain improved significantly with duloxetine vs. placebo (-2.57 vs. -1.80; adjusted mean difference: -0.77; 95% CI: -1.11 to -0.43; P<0.0001). PMID 29713194 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications